**Nakiki SE Aims to Be Germany’s First Public Company with Bitcoin-Only Treasury Strategy**
Nakiki SE has announced its intention to fully embrace a bitcoin treasury strategy, positioning itself to become the first publicly listed company in Germany to adopt a bitcoin-only reserve asset approach, akin to the strategy popularized by Michael Saylor. The announcement was made today, with plans to propose a name change and a revised business purpose at the company’s annual general meeting scheduled for the latter half of 2025.
In addition to the strategic shift, Nakiki SE is actively engaging with key investors to secure funding through share issuances aimed at facilitating its bitcoin acquisitions. The company stated, “The course for building a Bitcoin portfolio was set today following discussions with potential investors, placing banks, and Bitcoin experts.”
This move aligns with a growing trend among German firms that are increasingly recognizing Bitcoin as a viable treasury asset. A notable example is Evertz Pharma GmbH, which recently made headlines as the first private German company to implement a strategic Bitcoin reserve. Dominik Evertz, the managing director of Evertz Pharma, emphasized the importance of Bitcoin in their financial strategy, stating, “Bitcoin, as a scarce and globally tradable asset, complements our reserves and strengthens the long-term resilience of our company.”
While Bitcoin Group SE is another publicly traded entity in Germany that holds Bitcoin on its balance sheet, it does not actively pursue the same bitcoin treasury strategy that Nakiki SE aims to implement. This distinction is crucial as Nakiki SE seeks to differentiate itself by focusing solely on this innovative business model.
The adoption of Bitcoin as a treasury reserve asset has surged globally over the past year, with 256 companies and entities now holding Bitcoin on their balance sheets. The influence of Michael Saylor’s strategy has been significant, with companies like his holding over 597,000 BTC, reflecting a bitcoin net asset value of $64.7 billion and a remarkable one-year return of 210%. This long-term commitment to Bitcoin and transparency has inspired firms like Nakiki SE and Evertz Pharma to explore similar paths.
As more companies look for alternatives to traditional reserve assets, Nakiki SE’s initiative underscores Bitcoin’s growing role as a strategic asset in corporate finance.
**FAQ**
**What is Nakiki SE’s new strategy?**
Nakiki SE plans to adopt a bitcoin-only treasury strategy, aiming to become the first publicly listed company in Germany to focus solely on Bitcoin as a reserve asset.
